Cargando…

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests

It remains unclear whether screening for advanced fibrosis in the community can identify the subgroup of people with nonalcoholic fatty liver disease (NAFLD) at higher risk for development of liver‐related complications. We aimed to determine the prognostic value of baseline noninvasive fibrosis tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Amy L., Hayward, Kelly L., Patel, Preya, Horsfall, Leigh U., Cheah, Alvin Ee Zhiun, Irvine, Katharine M., Russell, Anthony W., Stuart, Katherine A., Williams, Sue, Hartel, Gunter, Valery, Patricia C., Powell, Elizabeth E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948588/ https://www.ncbi.nlm.nih.gov/pubmed/34783191 http://dx.doi.org/10.1002/hep4.1852

Ejemplares similares

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Irvine, Katharine M., et al.
Publicado: (2021)

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation
por: Gadd, Victoria L., et al.
Publicado: (2016)

A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At‐Risk Populations in Primary Care
por: Patel, PreyaJanubhai, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics
por: Elangovan, Harendran, et al.
Publicado: (2020)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
por: Lee, Dae Ho
Publicado: (2020)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2020)

Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
por: Yang, Hye Ran
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

The role of noninvasive tests and liver biopsy in the diagnosis of nonalcoholic fatty liver disease
por: Isabela Andronescu, Craita, et al.
Publicado: (2018)

Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM
por: Hayward, Kelly Lee, et al.
Publicado: (2021)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism
por: Radford-Smith, Daniel E., et al.
Publicado: (2022)

Noninvasive Quantitative Detection Methods of Liver Fat Content in Nonalcoholic Fatty Liver Disease
por: Lv, Shujing, et al.
Publicado: (2018)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
por: Zhou, Jiang-Hua, et al.
Publicado: (2019)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care
por: Gracen, Lucy, et al.
Publicado: (2022)

Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease
por: Lee, Jiwoo, et al.
Publicado: (2020)

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis
por: Ahn, Sang Bong, et al.
Publicado: (2020)

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies
por: Hayward, Kelly L, et al.
Publicado: (2020)

Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease
por: Hayashi, Tatsuya, et al.
Publicado: (2017)

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
por: Shi, Yi-Wen, et al.
Publicado: (2021)

Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies
por: Reinshagen, Mona, et al.
Publicado: (2023)

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
por: Hernandez Roman, Jose, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
por: Bassal, Tamara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dtk0aeltp9uj8kdbsibqu61e9f